awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q31044175-EC8A2436-4666-4012-B653-4EED31A192A5
Q31044175-EC8A2436-4666-4012-B653-4EED31A192A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31044175-EC8A2436-4666-4012-B653-4EED31A192A5
The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.
P2860
Q31044175-EC8A2436-4666-4012-B653-4EED31A192A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31044175-EC8A2436-4666-4012-B653-4EED31A192A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
33dc5395adc09daedcacf0fe785d7ba4a4cb6609
P2860
A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.